Clover Health Downgraded to Underperform From Neutral At BofA
June 10, 2021 at 08:26 AM EDT
BofA analyst Kevin Fischbeck downgraded Clover Health Investments to Underperform from Neutral with an unchanged price target of $10.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|